JUNSHI BIO Appoints Chen Liang as Independent Non-Executive Director

Stock News06-26

JUNSHI BIO (ASX: 01877) has announced that the resolution regarding the election of Mr. Chen Liang as an independent non-executive director was approved at the Annual General Meeting held on June 26, 2026.

His appointment as an independent non-executive director became effective on the date of the AGM, June 26, 2026.

Effective from the same date, Mr. Li Zhongxian was appointed as Chairman of the Audit Committee and the Remuneration and Appraisal Committee, as well as a member of the Strategy and ESG Committee.

Mr. Chen Liang was appointed as a member of the Audit Committee and the Compliance Committee.

The terms of these appointments are effective from the date of the shareholders' meeting approval, June 26, 2026, and will last until the conclusion of the fourth board of directors' term.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment